Search results for "poros"

showing 10 items of 1076 documents

New Trends in the Treatment of Osteoporosis

1998

Osteoporosis is “a systemic disease characterized by a reduction in bone mass and a microarchitectonic alteration of the skeleton, with a consequent increase in skeleton fragility and susceptibility to fractures”, as defined by the last Consensus Development Conference1. With this definition, the alteration in skeletal structure, which is not yet easy to evaluate, becomes an important factor determining the risk of fracture of the osteoporotic patient, in addition to the bone mass, which to certain limit can be easily evaluated. This is an aspect that may create some problems at the time of taking a decision on how to proceed with a subject with decreased bone mass. Currently, the measureme…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentOsteoporosismedicinemedicine.diseaseIntensive care medicineConsensus developmentbusinessSkeleton (computer programming)Reduction (orthopedic surgery)Bone massBone remodeling
researchProduct

Osteoporosis, densidad mineral ósea y complejo CKD-MBD (II): implicaciones terapéuticas

2019

Resumen: La osteoporosis (OP) y la enfermedad renal crónica (ERC) influyen independientemente en la salud ósea. Numerosos pacientes con ERC presentan una disminución de densidad mineral ósea (DMO), un elevado riesgo de fracturas por fragilidad ósea y un incremento de su morbimortalidad. Con el envejecimiento de la población estos hechos no son dependientes solo de la «osteodistrofia renal» sino también de la OP asociada. Dado que la DMO tiene capacidad predictiva en pacientes con ERC (parte I), ahora analizaremos las implicaciones terapéuticas derivadas. Análisis post hoc de estudios aleatorizados han mostrado que fármacos como alendronato, risedronato, raloxifeno, teriparatida o denosumab …

medicine.medical_specialtyeducation.field_of_studyHyperparathyroidismbusiness.industryPopulationOsteoporosis030232 urology & nephrologyurologic and male genital diseasesmedicine.diseaselcsh:Diseases of the genitourinary system. Urologylcsh:RC870-92303 medical and health sciences0302 clinical medicineDenosumabNephrologyInternal medicinemedicineTeriparatideRaloxifeneRenal osteodystrophy030212 general & internal medicinebusinesseducationmedicine.drugKidney diseaseNefrología
researchProduct

Effectiveness of Rehabilitative Intervention on Pain, Postural Balance, and Quality of Life in Women with Multiple Vertebral Fragility Fractures: A P…

2021

Patients with vertebral fragility fractures often experience chronic pain, postural and balance disorders, and poor quality of life (QoL). Although several studies have investigated the role of rehabilitation in severe osteoporosis, the effectiveness of this intervention in patients with multiple vertebral fractures is poorly known. The aim of our longitudinal cohort study is to evaluate the effectiveness of rehabilitation, including postural training, resistance exercises, and visual stabilization exercises, for a 7-week period, on the pain, postural balance, and QoL of subjects with at least two vertebral fragility fractures receiving denosumab and vitamin D. We investigated, before (T0) …

medicine.medical_specialtylcsh:Diseases of the musculoskeletal systemHistologymedicine.medical_treatmentOsteoporosisvertebral fragility fractures030209 endocrinology & metabolismPhysical Therapy Sports Therapy and RehabilitationArticlerehabilitation03 medical and health sciences0302 clinical medicineRheumatologyQuality of lifePostural BalanceMedicineosteoporosiOrthopedics and Sports Medicinepain030212 general & internal medicineProspective cohort studypostural balanceRehabilitationbusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaPosturographyChronic painmedicine.diseaseosteoporosisDenosumabquality of lifePhysical therapylcsh:RC925-935Anatomybusinessvertebral fragility fracturemedicine.drugJournal of functional morphology and kinesiology
researchProduct

Oral Squamous Cell Carcinoma Mimicking Medication-Related Osteonecrosis of the Jaws (MRONJ): A Case Series

2021

(1) Background: Medication-related osteonecrosis of the jaw (MRONJ) is a potential adverse drug reaction of antiresorptive and/or antiangiogenic treatment. MRONJ is mostly diagnosed by anamnestic data, clinical examination and radiological findings, with signs and symptoms often unspecific. On the other hand, oral squamous cell carcinoma (OSCC) is characteristic for its pleomorphic appearance (e.g., ulcer, mucous dehiscence, non-healing post-extractive socket). We report three cases where OSCC mimicked MRONJ lesions. (2) Patients: Three patients undergoing amino-bisphosphonate treatment for osteoporosis presented with areas of intraorally exposed jawbone and unspecific radiological signs co…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryOsteoporosisONJPhysical examinationRK1-715Dehiscencemedicine.diseaseMRONJDermatologyOral Squamous Cell CarcinomaMedication-Related Osteonecrosis of the Jaws MRONJ Case Seriesoral squamous cell carcinomastomatognathic diseasesosteonecrosis of the jawRadiological weaponDentistrymedicinebone exposureIn patientBasal cellOSCCOsteonecrosis of the jawbusinessAdverse drug reaction
researchProduct

Increased 2-Hydroxylation of Estrogen in Women with a Family History of Osteoporosis

2005

Recent studies indicate that women with predominant estrogen metabolism through the 2-hydroxyl (inactive) pathway have lower bone mineral density (BMD) compared with those with predominant 16alpha-hydroxylation (active). Although many factors have been identified to affect estrogen metabolism, the role of a family history of osteoporosis remains unknown. The objective of this study was to investigate the influence of family history of osteoporosis and other clinical factors on estrogen hydroxylation. This was a cross-sectional study conducted in a university-based research center from May 2002 to February 2004. The participants included 175 otherwise healthy postmenopausal women at least 1 …

medicine.medical_specialtymedicine.drug_classEndocrinology Diabetes and MetabolismUrinary systemClinical BiochemistryOsteoporosisHydroxylationBiochemistryArticleHydroxylationchemistry.chemical_compoundEndocrinologyBone DensityInternal medicinemedicineHumansosteoporosiFemurFamily historyAgedBone mineralPostmenopausal womenbusiness.industryBiochemistry (medical)EstrogensMiddle Agedmedicine.diseaseEstrogenCross-Sectional StudiesEndocrinologychemistryEstrogenOsteoporosiswomen health.CalciumFemalebusinessThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Prevalence of Vertebral Fractures and Their Prognostic Significance in the Survival in Patients with Chronic Kidney Disease Stages 3‒5 Not on Dialysis

2020

Background: The prevalence of vertebral fractures (VF) and their association with clinical risk factors and outcomes are poorly documented in chronic kidney disease (CKD) cohorts. The aim of the study was to evaluate the prevalence of VF in patients with non-dialysis dependent CKD (NDD-CKD), their value in predicting mortality and its correlation with parameters of bone mineral metabolism and vascular calcification. Materials and Methods: 612 NDD 3‒5 stage CKD patients participating in the OSERCE-2 study, a prospective, multicenter, cohort study, were prospectively evaluated and categorized into two groups according to presence or absence of VF at enrollment. VF were assessed with lateral r…

medicine.medical_specialtymedicine.medical_treatmentOsteoporosis030232 urology & nephrologylcsh:Medicine030209 endocrinology & metabolismLogistic regressionArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineRisk factorSurvival analysisDialysisVascular diseasebusiness.industrylcsh:RGeneral Medicinefracturesmedicine.diseasevascular calcificationbusinesschronic kidney diseaseCohort studyKidney diseaseJournal of Clinical Medicine
researchProduct

Real-world Adherence and Persistence with Bisphosphonate Therapy in Postmenopausal Women: A Systematic Review

2018

Abstract Purpose Bisphosphonate therapy is a well-established and effective treatment for postmenopausal osteoporosis and the prevention of osteoporotic fracture. However, poor adherence to and poor persistence with bisphosphonate therapy may reduce its benefits. Previous studies have documented the poor rates of adherence and persistence among postmenopausal women with osteoporosis. The objective of this systematic literature review was to evaluate adherence, persistence, and the impact of adherence and persistence on fracture risk in postmenopausal women with diagnosed osteoporosis. Methods Articles eligible for review included observational studies of the real-world use of bisphosphonate…

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisMEDLINE02 engineering and technology030204 cardiovascular system & hematologyMedication AdherencePersistence (computer science)03 medical and health sciences020210 optoelectronics & photonics0302 clinical medicineInternal medicine0202 electrical engineering electronic engineering information engineeringmedicineHumansPharmacology (medical)Osteoporosis PostmenopausalPharmacologyBone Density Conservation AgentsDiphosphonatesbusiness.industryBisphosphonatemedicine.diseasePostmenopauseMenopauseObservational Studies as TopicTreatment OutcomeSystematic reviewFemaleObservational studybusinessOsteoporotic FracturesBiomedical sciencesClinical Therapeutics
researchProduct

Dental implants in patients treated with oral bisphosphonates. A bibliographic review

2010

Bisphosphonates inhibit bone resorption and are used to treat a range of pathologies, including Paget disease, osteoporosis, multiple myeloma and metastases associated with breast or prostate cancer. At present, there is no effective treatment for bisphosphonate induced osteonecrosis, so prevention is extremely important. Since quality of life deteriorates for those suffering osteonecrosis, maximum precautions should be taken with patients at risk, and especially whenever oral surgery, including dental implant placement, is contemplated. Dentists and oral or maxillofacial surgeons must keep up to date with the latest approaches to prevention, particularly when treating patients who are pres…

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisMEDLINEAdministration OralDentistryBone resorptionProstate cancerQuality of lifemedicineHumansDental implantGeneral DentistryMultiple myelomaDental ImplantsDiphosphonatesbusiness.industryOsteonecrosisBisphosphonatemedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgerybusinessJaw Diseases
researchProduct

Proposal for a preventive protocol for medication-related osteonecrosis of the jaw.

2021

Background Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse reaction experienced by some patients exposed to certain drugs (antiresorptives such as bisphosphonates or denosumab, and antiangiogenic drugs). From a review of the literature it appears that there is no uniform criterion when selecting preventive measures; these vary according to author. Likewise, the measures recommended are usually general, so that in few cases they result in specific actions to be applied depending on the different variables involved such as the type of drug used, the duration of its application, the underlying pathology, the presence or absence of risk factors, etc. The aim of this stud…

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisMEDLINEReviewsleep disturbancesolder people03 medical and health sciences0302 clinical medicinemedicineHumansIntensive care medicineAdverse effectDental implantGeneral DentistryUNESCO:CIENCIAS MÉDICASProtocol (science)dental implantOral Medicine and PathologyedentulismBone Density Conservation AgentsDiphosphonatesbusiness.industryOsteonecrosis030206 dentistrymedicine.diseaseDenosumabSystematic reviewOtorhinolaryngologyOsteoporosisSurgeryBisphosphonate-Associated Osteonecrosis of the JawbusinessOsteonecrosis of the jawmedicine.drug
researchProduct

Surgical treatment vs. conservative treatment in intravenous bisphosphonate-related osteonecrosis of the jaws. Systematic review

2017

AIMS To determine the success rates of the surgical and non-surgical treatments in the management of bisphosphonate-related osteonecrosis of the jaws (BRONJ). MATERIAL AND METHODS A systematic review of the literature was made. A PubMed Medline database search was performed in order to include clinical studies published in English,between2004 and 2014 with the following key-words: "BRONJ AND treatment" and "NOT osteoporosis". The following data was gathered: authors, title, year of publication, aim of study, level of evidence, sample size, treatment performed, treatment outcomes and follow-up. Studies including more than 20 patients with at least 6 months of follow-up, and that specify the …

medicine.medical_specialtymedicine.medical_treatmentOsteoporosisOdontologíaJawsReviewlaw.invention03 medical and health sciencesNecrosis0302 clinical medicineRandomized controlled triallawmedicineGeneral DentistryOral Medicine and PathologyMaxil·larsbusiness.industryGeneral surgery030206 dentistryEvidence-based medicineBisphosphonatemedicine.disease:CIENCIAS MÉDICAS [UNESCO]NecrosiCiencias de la saludSurgeryConservative treatmentSystematic reviewSequestrectomySample size determination030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASbusiness
researchProduct